Nkarta, Inc. - Common Stock — キャッシュフロー (NASDAQ:NKTX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -43.51 M-67.93 M-57 M-86.16 M-99.7 M-88.7 M -87.29 M 投資活動によるキャッシュフロー -210.08 M32.53 M-184.69 M79.02 M-129.56 M100.32 M 61.9 M 財務活動によるキャッシュフロー 329.82 M1.2 M219.01 M691 K226.08 M141 K 147 K フリーキャッシュフロー -43.51 M-67.93 M-57 M-86.16 M-99.7 M-89.91 M -88.39 M

ニュース

NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program

Nkarta社の社長Mahmoodが株式11,693ドル分を売却

Nkarta CEO Hastings sells $53,915 in NKTX stock

Nkarta (NKTX) president Nadir sells $11,693 in shares

Nkarta: Pushing Deeper Into A Discount Vs. Their Holdings, For No Real Reason (NKTX)

スティーフェル、Nkarta株の目標価格を12ドルから11ドルに引き下げ、買い推奨を維持

Stifel lowers Nkarta stock price target to $11 from $12, keeps Buy rating

Nkarta to present data on B-cell depleting therapy at rheumatology meeting

Nkarta (NKTX): Holding Its Support Steady Ahead Of First Data Readouts In 2025

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Nkarta (NASDAQ:NKTX)

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Alcoa (NYSE:AA), Americold Realty Trust (NYSE:COLD)